Literature DB >> 8564252

The roles of spinal adenosine receptors in the control of acute and more persistent nociceptive responses of dorsal horn neurones in the anaesthetized rat.

A J Reeve1, A H Dickenson.   

Abstract

1. We describe here the effects of intrathecal selective adenosine receptor agonists on acute and more persistent evoked responses of dorsal horn nociceptive neurones recorded in intact rats anaesthetized with halothane. 2. The effects of the A1 receptor agonist, N6-cyclopentyladenosine and the non-selective agonist 2-chloroadenosine as well as the A2a receptor agonist, 2-p-(2-carboxyethyl) phenethylamino-5'-N-ethylcarboxamidoadenosine hydrochloride were gauged on the C-, A delta-, A beta-fibre, post-discharge and wind-up responses produced by peripheral tanscutaneous stimulation. The antagonists, theophylline and 8(p-sulphophenyl) theophylline were also tested alone and to reverse the agonist effects. 3. Subcutaneous formalin (5%) was used to produce a more prolonged nociceptive response initiated by peripheral inflammation. 4. Both N6-cyclopentyladenosine and 2-chloroadenosine produced inhibitions of the C-fibre evoked responses, wind-up and post-discharge of the neurones with no significant effects on the A beta responses. By contrast, the A delta evoked responses were facilitated over the same time course and dose-range as the inhibitions. N6-cyclopentyladenosine was more potent and effective than 2-chloroadenosine. In marked contrast to these agonists, the A2a agonist produced only weak non-specific inhibitions. Theophylline and 8(p-sulphophenyl) theophylline alone had no effect on the acute responses but prevented or reversed inhibitory effects of N6-cyclopentyladenosine. 5. The formalin response was markedly inhibited by spinal N6-cyclopentyladenosine with both the acute first phase and more prolonged second phase being dose-dependently inhibited. N6-cyclopentyladenosine was considerably more potent on the formalin response than on the other neuronal measures. 6 The results suggest a role of adenosine Al receptors in the modulation of both acute and inflammatory nociception in the spinal cord.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8564252      PMCID: PMC1908979          DOI: 10.1111/j.1476-5381.1995.tb15057.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  39 in total

Review 1.  The role of purines in nociception.

Authors:  J Sawynok; M I Sweeney
Journal:  Neuroscience       Date:  1989       Impact factor: 3.590

Review 2.  Cloned adenosine A3 receptors: pharmacological properties, species differences and receptor functions.

Authors:  J Linden
Journal:  Trends Pharmacol Sci       Date:  1994-08       Impact factor: 14.819

3.  Autoradiographic localization of adenosine receptors in rat brain using [3H]cyclohexyladenosine.

Authors:  R R Goodman; S H Synder
Journal:  J Neurosci       Date:  1982-09       Impact factor: 6.167

4.  Intrathecal etorphine, fentanyl and buprenorphine on spinal nociceptive neurones in the rat.

Authors:  A H Dickenson; A F Sullivan; H J McQuay
Journal:  Pain       Date:  1990-08       Impact factor: 6.961

5.  Pharmacology of the spinal action of ketorolac, morphine, ST-91, U50488H, and L-PIA on the formalin test and an isobolographic analysis of the NSAID interaction.

Authors:  A B Malmberg; T L Yaksh
Journal:  Anesthesiology       Date:  1993-08       Impact factor: 7.892

6.  Adenosine A1 and A2 receptors of the substantia gelatinosa are located predominantly on intrinsic neurons: an autoradiography study.

Authors:  J I Choca; R D Green; H K Proudfit
Journal:  J Pharmacol Exp Ther       Date:  1988-11       Impact factor: 4.030

7.  Adenosine inhibition of synaptic transmission in the substantia gelatinosa.

Authors:  J Li; E R Perl
Journal:  J Neurophysiol       Date:  1994-10       Impact factor: 2.714

8.  Evidence for spinal N-methyl-D-aspartate receptor involvement in prolonged chemical nociception in the rat.

Authors:  J E Haley; A F Sullivan; A H Dickenson
Journal:  Brain Res       Date:  1990-06-04       Impact factor: 3.252

9.  Electrophysiological studies on the effects of intrathecal morphine on nociceptive neurones in the rat dorsal horn.

Authors:  Anthony H Dickenson; Ann F Sullivan
Journal:  Pain       Date:  1986-02       Impact factor: 6.961

Review 10.  Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential.

Authors:  K A Jacobson; P J van Galen; M Williams
Journal:  J Med Chem       Date:  1992-02-07       Impact factor: 7.446

View more
  15 in total

1.  The effect of ABT-702, a novel adenosine kinase inhibitor, on the responses of spinal neurones following carrageenan inflammation and peripheral nerve injury.

Authors:  R Suzuki; L C Stanfa; E A Kowaluk; M Williams; M F Jarvis; A H Dickenson
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

2.  The efficacy of a novel adenosine agonist (WAG 994) in postoperative dental pain.

Authors:  R A Seymour; J E Hawkesford; C M Hill; J Frame; C Andrews
Journal:  Br J Clin Pharmacol       Date:  1999-06       Impact factor: 4.335

Review 3.  Emerging drugs for migraine prophylaxis and treatment.

Authors:  Marcelo E Bigal; Abouch V Krymchantowski
Journal:  MedGenMed       Date:  2006-05-04

Review 4.  How do drugs relieve neurogenic pain?

Authors:  R Karlsten; T Gordh
Journal:  Drugs Aging       Date:  1997-11       Impact factor: 3.923

5.  Control of glutamatergic neurotransmission in the rat spinal dorsal horn by the nucleoside transporter ENT1.

Authors:  Michael A Ackley; Ricardo J M Governo; Carol E Cass; James D Young; Stephen A Baldwin; Anne E King
Journal:  J Physiol       Date:  2003-02-28       Impact factor: 5.182

6.  Mechanisms involved in the antinociception induced by systemic administration of guanosine in mice.

Authors:  A P Schmidt; A E Böhmer; C Schallenberger; C Antunes; R G Tavares; S T Wofchuk; E Elisabetsky; D O Souza
Journal:  Br J Pharmacol       Date:  2010-02-02       Impact factor: 8.739

7.  Intrathecal adenosine A1 receptor agonist attenuates hyperalgesia without inhibiting spinal glutamate release in the rat.

Authors:  Syuichiro Yamamoto; Osamu Nakanishi; Tomohiro Matsui; Noriyuki Shinohara; Hiroyuki Kinoshita; Clinton Lambert; Toshizo Ishikawa
Journal:  Cell Mol Neurobiol       Date:  2003-04       Impact factor: 5.046

8.  Enduring reversal of neuropathic pain by a single intrathecal injection of adenosine 2A receptor agonists: a novel therapy for neuropathic pain.

Authors:  Lisa C Loram; Jacqueline A Harrison; Evan M Sloane; Mark R Hutchinson; Paige Sholar; Frederick R Taylor; Debra Berkelhammer; Benjamen D Coats; Stephen Poole; Erin D Milligan; Steven F Maier; Jayson Rieger; Linda R Watkins
Journal:  J Neurosci       Date:  2009-11-04       Impact factor: 6.167

9.  Adenosine receptor subtype-selective antagonists in inflammation and hyperalgesia.

Authors:  Andras Bilkei-Gorzo; Osama M Abo-Salem; Alaa M Hayallah; Kerstin Michel; Christa E Müller; Andreas Zimmer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-01-10       Impact factor: 3.000

10.  Analgesic and Anti-Inflammatory Activities of Methanol Extract of Cissus repens in Mice.

Authors:  Ching-Wen Chang; Wen-Te Chang; Jung-Chun Liao; Yung-Jia Chiu; Ming-Tsuen Hsieh; Wen-Huang Peng; Yu-Chin Lin
Journal:  Evid Based Complement Alternat Med       Date:  2012-09-06       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.